hPV19

· Suzhou Stainwei Biotech Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hPV19, covering 2018-04-20 to 2018-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors [Phase 1]